Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Dermatologic Therapy|May 4, 2020
Successful treatment of mogamulizumab-resistant mycosis fungoides with mogamulizumab plus etoposide combined therapy: Investigation of the immunomodulatory effects of etoposide on the tumor microenvironmentKentaro Ohuchi, Taku Fujimura, Yumi Kambayashi, et al.
Frontiers in Immunology|November 12, 2020
Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell CarcinomaYota Sato, Taku Fujimura, Takanori Hidaka, et al.
Experimental Dermatology|August 24, 2017
Cytotoxic antimelanoma drugs suppress the activation of M2 macrophagesTaku Fujimura, Aya Kakizaki, Yumi Kambayashi, et al.
Anticancer Research|December 27, 2017
The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine OriginYumi Kambayashi, Taku Fujimura, Sadanori Furudate, et al.
Melanoma Research|July 14, 2020
Increased serum CCL26 level is a potential biomarker for the effectiveness of anti-PD1 antibodies in patients with advanced melanomaTaku Fujimura, Kayo Tanita, Kentaro Ohuchi, et al.
Frontiers in Oncology|October 17, 2019
Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell LymphomaKayo Tanita, Taku Fujimura, Yota Sato, et al.
Frontiers in Medicine|May 14, 2019
Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced MelanomaTaku Fujimura, Yota Sato, Kayo Tanita, et al.
Pageof 2